10-Q: NuScale Power Corporation Reports Third Quarter 2024 Results, Navigates Transition to Commercialization

NuScale Power Corporation's Q3 2024 results reflect a transition from R&D to commercialization, marked by reduced expenses and a new revenue-generating contract, despite ongoing losses.

Summary

• NuScale Power Corporation reported a net loss of $45.55 million for the third quarter of 2024, compared to a net loss of $58.33 million in the same period of 2023.
• The company's revenue decreased significantly to $0.475 million in Q3 2024 from $6.95 million in Q3 2023, primarily due to the termination of the CFPP LLC contract.
• Research and development expenses decreased to $12.16 million in Q3 2024 from $63.73 million in Q3 2023, due to cost optimization and the CFPP LLC contract termination.
• General and administrative expenses increased slightly to $17.02 million in Q3 2024 from $16.40 million in Q3 2023.
• The company's cash and cash equivalents stood at $111.63 million as of September 30, 2024, with an additional $45 million in short-term investments.
• NuScale has a restricted cash balance of $5.1 million related to a letter of credit for the CFPP LLC settlement.
• The company has a long-lead material work in process valued at $41.61 million and a corresponding liability of $33.06 million.
• NuScale has entered into a new revenue-generating agreement with a customer, with revenue to be recognized as performance obligations are achieved.
• The company reduced its workforce by 28% in January 2024, resulting in a one-time charge of $3.24 million.
• NuScale expects the NRC to complete its review and grant SDA approval by July 31, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is making progress in cost optimization and securing new revenue streams, it is still facing significant challenges, including ongoing losses, legal risks, and the need for additional funding. The loss of the CFPP LLC contract is a major setback, and the SEC inquiry adds further uncertainty.

Positives

• The company's net loss decreased compared to the same period last year.
• Research and development expenses were significantly reduced due to cost optimization and the termination of the CFPP LLC contract.
• NuScale secured a new revenue-generating agreement, indicating progress in commercialization.
• The company has a solid cash position with $111.63 million in cash and cash equivalents and $45 million in short-term investments.
• The company is actively managing expenses and cash reserves.
• The company expects to receive SDA approval from the NRC by July 31, 2025.

Negatives

• Revenue decreased significantly due to the termination of the CFPP LLC contract.
• The company continues to experience operating losses and negative operating cash flow.
• The company incurred a one-time charge of $3.24 million due to workforce reduction.
• The company is involved in multiple legal proceedings, including shareholder class action lawsuits.
• The company is subject to an SEC inquiry regarding employment, severance, and confidentiality agreements.
• The company may require additional funding, which may not be available on acceptable terms.

Risks

• The company is involved in multiple legal proceedings, including shareholder class action lawsuits, which could have a material adverse effect on the business.
• The company is subject to an SEC inquiry, the outcome of which is uncertain.
• The company may require additional funding, which may not be available on acceptable terms.
• The company's projections rely on customer-sourced income and DOE funds, which are not assured.
• The company is dependent on the NRC's approval of the SDA application by July 31, 2025.
• The company's success depends on the commercialization of its SMR technology, which is subject to various risks and uncertainties.

Future Outlook

The company believes it has sufficient funds to cover required R&D activities and operating cash needs for the next twelve months, due to cost optimization plans, utilization of the ATM Program, and execution of customer contracts. Management plans to prudently manage expenses and cash reserves into the future, recognizing the need to secure additional customer commitments to support long-term operations. The company expects the NRC to complete its review and grant SDA approval by July 31, 2025.

Management Comments

• Management believes they have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months.
• Management plans to prudently manage its expenses and cash reserves into the future.
• Management recognizes the need to secure additional customer commitments to support long-term operations.

Industry Context

The report reflects NuScale's ongoing transition from a research and development focused company to a commercial entity in the small modular reactor (SMR) industry. The company is navigating the challenges of commercializing its technology, including securing customer contracts and regulatory approvals, while managing costs and legal risks. The termination of the CFPP LLC contract highlights the volatility and risks associated with early-stage projects in the nuclear energy sector. The company's focus on cost optimization and securing new revenue streams is consistent with the broader industry trend of seeking more efficient and cost-effective nuclear energy solutions.

Comparison to Industry Standards

• NuScale's financial performance is difficult to directly compare to established nuclear power plant operators due to its focus on SMR technology and its current stage of development.
• Companies like Westinghouse and Framatome, which are involved in large-scale nuclear power plant construction and maintenance, have different revenue models and cost structures.
• Other SMR developers, such as Rolls-Royce SMR and TerraPower, are also in the early stages of commercialization, making direct comparisons challenging.
• NuScale's reliance on government funding and cost-share agreements is common among SMR developers, reflecting the high capital costs and long development timelines associated with nuclear technology.
• The company's focus on securing regulatory approvals from the NRC is a critical step for all SMR developers in the US market.
• The company's ability to secure new customer contracts and generate revenue will be a key factor in its long-term success, as it transitions away from government funding.

Management Changes

Legal Proceedings

• The company is involved in a lawsuit filed by purported members and/or option holders of NuScale LLC.
• The company is involved in multiple shareholder class action lawsuits.
• The company is subject to an SEC inquiry regarding employment, severance, and confidentiality agreements.

Related Party Transactions

• The company has entered into strategic agreements with Fluor, whereby Fluor or the Company perform services for one another.
• For the three months ended September 30, 2024, the company incurred expenses of $0.229 million and earned revenue of $0.047 million from Fluor.
• For the nine months ended September 30, 2024, the company incurred expenses of $0.767 million and earned revenue of $0.570 million from Fluor.

Stakeholder Impact

• Shareholders are impacted by the company's ongoing losses and legal risks.
• Employees were impacted by the workforce reduction in January 2024.
• Customers are impacted by the company's ability to deliver its SMR technology.
• Suppliers are impacted by the company's financial stability and ability to pay for goods and services.
• Creditors are impacted by the company's ability to repay its debts.

Next Steps

• The company will continue to respond to the SEC's requests for information.
• The company will continue to pursue regulatory approvals for its SMR technology.
• The company will focus on securing new customer contracts and generating revenue.
• The company will continue to manage expenses and cash reserves prudently.
• The company will continue to defend itself in ongoing legal proceedings.

Key Dates

Keywords

SMR, NuScale, Nuclear Power, Small Modular Reactor, NRC, Design Certification, Financial Results, Commercialization, Cost Optimization, Warrant Liabilities